Electrophysiology Catheters Market Report 2026

Electrophysiology Catheters Market Overview

• Electrophysiology Catheters market size has reached to $7.58 billion in 2025 • Expected to grow to $13.83 billion in 2030 at a compound annual growth rate (CAGR) of 12.8% • Growth Driver: Rising Cardiovascular Disease Rates Drive Growth In Electrophysiology Catheter Market • Market Trend: Innovative Cardiac Ablation Technologies Enhancing Safety And Precision In Arrhythmia Treatment • North America was the largest region in 2025.

What Is Covered Under Electrophysiology Catheters Market?

Electrophysiology catheters are specialized medical devices used in the field of electrophysiology to diagnose and treat heart rhythm disorders. These catheters are inserted into the heart through blood vessels to record electrical activity, map electrical pathways, and deliver therapeutic interventions. These catheters are typically used in procedures performed in specialized areas like electrophysiology labs within hospitals or clinics. The main electrophysiology catheters are electrophysiology diagnostic catheters, electrophysiology ablation catheters, and others. Electrophysiology diagnostic catheters are specialized medical devices used to diagnose heart rhythm disorders. It is distributed through both online and offline channels and is applied for diagnosis and monitoring, treatment of cardiac arrhythmias, imaging and mapping, and others. It is used by various end users, including hospitals, ambulatory surgical centers, cardiac catheterization labs, and others.

What Is The Electrophysiology Catheters Market Growth Forecast?

The electrophysiology catheters market size is expected to see rapid growth in the next few years. It will grow to $13.83 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to aging population with heart rhythm disorders, increasing demand for minimally invasive cardiac treatments, expansion of ambulatory cardiac centers, rising awareness of arrhythmia management, growing healthcare spending on cardiac care. Major trends in the forecast period include rising adoption of catheter-based arrhythmia treatments, growing demand for advanced cardiac mapping catheters, increasing use of minimally invasive electrophysiology procedures, shift toward high-precision ablation catheters, rising procedure volumes in dedicated electrophysiology labs.

Global Electrophysiology Catheters Market Segmentation

1) By Product Type: Electrophysiology Diagnostic Catheters, Electrophysiology Ablation Catheters, Other Product Types 2) By Distribution Channel: Online, Offline 3) By Application: Diagnosis And Monitoring, Treatment Of Cardiac Arrhythmias, Imaging And Mapping, Other Applications 4) By End User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Labs, Other End Users Subsegments: 1) By Electrophysiology Diagnostic Catheters: Mapping Catheters, Diagnostic Catheters For Arrhythmia Detection 2) By Electrophysiology Ablation Catheters: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters 3) By Other Product Types: Electrophysiology Guidewires, Electrophysiology Sheaths And Introducers, Electrophysiology Stimulator Electrodes

What Is The Driver Of The Electrophysiology Catheters Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the electrophysiology catheter market going forward. Cardiovascular diseases are a group of conditions that affect the heart and blood vessels, often leading to complications such as heart attacks, strokes, and heart failure. Cardiovascular disease rates are on the rise owing to several factors, such as unhealthy diets, sedentary lifestyles, smoking, and excessive alcohol consumption. Electrophysiology catheters are required for cardiovascular diseases to accurately diagnose and treat heart rhythm disorders by mapping electrical activity and delivering targeted therapeutic interventions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, is a US-based, government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for approximately one in every three deaths. Therefore, the increasing prevalence of cardiovascular diseases is driving the electrophysiology catheter industry.

Key Players In The Global Electrophysiology Catheters Market

Major companies operating in the electrophysiology catheters market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Biotronik SE & Co KG, MicroPort Scientific Corporation, AtriCure Inc., Stereotaxis Inc., Acutus Medical Inc., Imricor Medical Systems Inc., OSYPKA AG, CardioFocus Inc., Terumo Corporation, Asahi Intecc Co Ltd, Cook Medical, Japan Lifeline Co Ltd, Lepu Medical Technology Co Ltd, Kardium Inc., CathVision ApS, APN Health LLC

Global Electrophysiology Catheters Market Trends and Insights

Major companies operating in the electrophysiology catheters market are focusing on developing innovative solutions such as pulsed field ablation to enhance the safety, precision, and efficiency of cardiac arrhythmia treatments. Pulsed field ablation (PFA) refers to a non-thermal cardiac ablation technique that uses high-voltage, short-duration electrical pulses to selectively destroy abnormal heart tissue while minimizing damage to surrounding structures. For instance, in October 2024, Medtronic Plc., an Ireland-based medical technology company, received FDA approval for the Affera Mapping and Ablation System and the Sphere-9 Catheter. It is an innovative, all-in-one electrophysiology tool that combines high-density cardiac mapping and dual-energy ablation (pulsed field and radiofrequency) in a single catheter. This system simplifies complex arrhythmia procedures by enabling a single catheter to map and ablate with high precision, improving workflow efficiency and reducing procedure times. Its purpose is to provide safer, more effective treatment for persistent atrial fibrillation and atrial flutter, with demonstrated clinical safety and efficacy benefits for both patients and physicians.

What Are Latest Mergers And Acquisitions In The Electrophysiology Catheters Market?

In January 2024, CardioFocus, a US-based medical device company, acquired the Electrophysiology Technology division of Galvanize Therapeutics for an undisclosed amount. The acquisition combines the CENTAURI System, a pulsed electric field generator CE marked and available in the EU and UK, along with the QuickShot catheter ablation system, which is currently in development. Additionally, it includes a comprehensive intellectual property portfolio featuring licenses to several foundational patent families for pulsed electric field therapies. Galvanize Therapeutics is a US-based manufacturer of electrophysiology catheters.

Regional Outlook

North America was the largest region in the electrophysiology catheters market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Electrophysiology Catheters Market?

The electrophysiology catheters market consists of sales of mapping catheters, biosensing catheters, electrode catheters and cryoablation catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.